Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 1, 1999Expert Opinion on Investigational Drugs

Efavirenz: shifting the HAART paradigm in adult HIV-1 infection

View Full Paper
Ask AI
Bookmark
Share

Authors

GMGraeme MoyleChelsea and Westminster Hospital NHS Foundation Trust

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Graeme Moyle (1999) studied this question.

synapsesocial.com/papers/6a6f9e9178a11c550e095904https://doi.org/10.1517/13543784.8.4.473
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy1997 · 1,925 citations
  2. 2The Effect of Prescribed Daily Dose Frequency on Patient Medication Compliance1990 · 797 citations
  3. 3A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors1998 · 2,409 citations
  4. 4A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less1997 · 2,686 citations
  5. 5Crystal Structure at 3.5 Å Resolution of HIV-1 Reverse Transcriptase Complexed with an Inhibitor1992 · 1,914 citations